Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

ELISA Kit Determination Methods: Principles, Procedures, and Technical Guidelines

ELISA (Enzyme-Linked Immunosorbent Assay) kit determination methods are widely used bioanalytical techniques for the quantitative and qualitative detection of proteins, antibodies, antigens, hormones, and small molecules in biological samples. This article provides a comprehensive technical overview of ELISA kit testing, covering assay principles, sample preparation, testing procedures, method validation, quality control requirements, and typical applications in clinical diagnostics, pharmaceutical development, and research laboratories.

Technical Overview

ELISA (Enzyme-Linked Immunosorbent Assay) is an immunological analytical technique that uses enzyme-labeled antibodies or antigens to detect and quantify target analytes in liquid samples. The method relies on the highly specific binding between an antigen and its corresponding antibody, combined with an enzymatic colorimetric reaction that converts a substrate into a measurable colored product. The signal intensity, typically read at a specific wavelength (for example, 450 nm when TMB substrate is used with HRP conjugate), is directly proportional or inversely proportional to the concentration of the target analyte, depending on the assay format.

A standard ELISA kit generally contains a pre-coated 96-well microplate, standards or calibrators with known concentrations, detection antibodies conjugated with enzymes (commonly horseradish peroxidase, HRP, or alkaline phosphatase, ALP), chromogenic substrate (such as TMB), wash buffer, stop solution, and detailed instructions for use. ELISA is favored for its high sensitivity (often reaching pg/mL to ng/mL detection limits), high throughput capability, relatively low cost, and ease of operation. Method development and routine testing should follow recognized quality frameworks such as ISO 17025 for laboratory competence, ISO 15189 for medical laboratories, and applicable national or international standards for immunoassay performance evaluation.

Testing Samples

Serum

Serum is the most common sample matrix for ELISA testing. Whole blood is collected using serum separator tubes or plain tubes, allowed to clot at room temperature for 30 to 60 minutes, and then centrifuged at 1,000–2,000 × g for 10–15 minutes. The supernatant serum is carefully transferred to clean tubes. Hemolyzed, lipemic, or contaminated samples may interfere with colorimetric readings and should be avoided or noted during interpretation.

Plasma

Plasma is obtained by collecting whole blood into anticoagulant tubes containing EDTA, heparin, or citrate, followed by centrifugation within 30 minutes of collection. The choice of anticoagulant must be compatible with the specific kit, since certain anticoagulants can interfere with antibody-antigen binding or enzymatic reactions. Plasma samples should be free of fibrin clots before loading onto the plate.

Cell Culture Supernatant

Cell culture media are collected from in vitro cell experiments, centrifuged at 1,000 × g for 10 minutes to remove cells and debris, and assayed directly or after dilution. This sample type is frequently used for cytokine and growth factor quantification in immunology and drug screening studies.

Tissue Homogenates

Tissues are rinsed in cold PBS to remove residual blood, weighed, minced, and homogenized in an appropriate volume of PBS or lysis buffer, often supplemented with protease inhibitors. The homogenate is centrifuged at 5,000–10,000 × g for 10–15 minutes at 4 °C, and the clear supernatant is collected. Results are usually normalized to total protein concentration or tissue weight.

Urine, Saliva, Cerebrospinal Fluid, and Other Body Fluids

Other biological fluids, including urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid, milk, and amniotic fluid, may be tested when the kit insert specifies compatibility. These samples are typically centrifuged to remove particulates and stored frozen if not analyzed immediately. Repeated freeze-thaw cycles should be minimized to prevent analyte degradation.

Sample Storage Requirements

  • Store samples at 2–8 °C if analyzed within 24 hours.
  • For longer storage, freeze samples at -20 °C or -80 °C in aliquots to avoid repeated freeze-thaw cycles.
  • Avoid using sodium azide as a preservative in samples for HRP-based assays, as it inhibits enzyme activity.
  • Record sample collection time, storage conditions, and any visible hemolysis or lipemia for traceability.

Testing Items

ELISA kits are available for a broad range of analyte categories, including:

  • Cytokines and chemokines, such as IL-1β, IL-2, IL-6, IL-10, TNF-α, IFN-γ, and MCP-1.
  • Hormones and endocrine markers, such as insulin, cortisol, thyroid hormones, and reproductive hormones.
  • Infectious disease markers, including antibodies or antigens for viruses and bacteria used in serological screening.
  • Tumor markers, such as CEA, AFP, PSA, and CA125.
  • Adhesion molecules, receptors, and signaling proteins, such as ICAM-1, VEGF, and PD-L1.
  • Food safety and veterinary analytes, including allergens, drug residues, mycotoxins, and hormones in animal products.
  • Drug candidates, biomolecules, and anti-drug antibodies in pharmacokinetic and immunogenicity studies.

Before testing, users should verify that the kit's target analyte, species reactivity, sample matrix compatibility, and measuring range match the intended study design.

Testing Methods

Assay Formats

Four principal ELISA formats are used, and the selection depends on the nature and concentration of the target analyte:

  • Direct ELISA: The antigen is immobilized on the plate and detected by an enzyme-labeled primary antibody. It is simple and fast but may have lower sensitivity and specificity.
  • Indirect ELISA: The antigen is immobilized, and detection uses an unlabeled primary antibody followed by an enzyme-labeled secondary antibody. It offers higher sensitivity and flexibility.
  • Sandwich ELISA: The analyte is captured between an immobilized capture antibody and a detection antibody. This format provides the highest specificity and sensitivity and is the most widely used format for quantifying proteins.
  • Competitive ELISA: The sample analyte competes with a labeled reference antigen or antibody for binding sites. Signal intensity is inversely proportional to analyte concentration, making this format suitable for small molecules with a single epitope.

Standard Operating Procedure

A typical sandwich ELISA determination is performed according to the following workflow. All reagents must be equilibrated to room temperature (20–25 °C) before use, and each standard and sample should be assayed in duplicate or triplicate.

  • Reagent preparation: Reconstitute standards, dilute wash buffer concentrate, and prepare detection antibody and HRP conjugate working solutions according to the kit insert.
  • Sample loading: Add standards, blank, controls, and diluted samples into the assigned wells of the pre-coated plate.
  • Incubation: Incubate the plate for the specified time (commonly 30–120 minutes) at 37 °C or room temperature to allow antigen-antibody binding.
  • Washing: Aspirate the liquid from each well and wash 3–5 times with wash buffer, ensuring complete removal of residual liquid to minimize background.
  • Detection antibody addition: Add the biotinylated or enzyme-labeled detection antibody and incubate as specified, followed by another washing cycle.
  • Substrate reaction: Add TMB substrate and incubate in the dark for 10–20 minutes until color development is adequate.
  • Stop reaction: Add stop solution to each well in the same order and timing as the substrate addition; the color changes from blue to yellow.
  • Reading: Measure absorbance at 450 nm within 5–15 minutes using a microplate reader, with wavelength correction at 570 nm or 630 nm if available.

Standard Curve and Data Calculation

The optical density (OD) values of the standards are plotted against their known concentrations to generate a calibration curve. A four-parameter logistic (4PL) curve fit is recommended for most sandwich ELISA kits because it accurately models the sigmoidal dose-response relationship; a linear or log-log fit may be acceptable within a narrow concentration range. Sample concentrations are interpolated from the curve and multiplied by the dilution factor. Results falling outside the calibration range should be re-assayed after appropriate dilution. The coefficient of determination (R²) should typically be ≥ 0.99 for a valid run.

Method Validation and Performance Parameters

When establishing or verifying an ELISA method, the following performance characteristics should be evaluated in accordance with the kit insert and applicable quality guidelines, such as ISO 17025 laboratory requirements and relevant pharmacopeial or national immunoassay standards:

  • Sensitivity: The minimum detectable concentration, defined as the analyte concentration corresponding to the blank signal plus two or three standard deviations.
  • Specificity: The degree of cross-reactivity with structurally related molecules, which should be negligible.
  • Precision: Intra-assay (within-run) CV should generally be below 10%, and inter-assay (between-run) CV below 15%.
  • Accuracy and recovery: Spike recovery in the sample matrix is typically acceptable between 80% and 120%.
  • Linearity: Serial dilutions of high-concentration samples should show consistent recovery after back-calculation, demonstrating minimal matrix effects.
  • Stability: Verification that kit reagents and processed samples remain stable under stated storage conditions.

Quality Control During Testing

  • Run blank wells, zero wells, and quality control samples of known high and low concentration in every plate.
  • Confirm that the standard curve meets the acceptance criteria defined in the kit instructions.
  • Use calibrated pipettes, a validated microplate reader, and a calibrated thermostat or incubator.
  • Maintain consistent incubation timing and washing efficiency across all wells to reduce edge effects and variability.
  • Document lot numbers, expiration dates, operator identity, and instrument readings for full traceability.

Applications

ELISA kit determination methods serve a wide spectrum of laboratory and industrial applications:

  • Clinical diagnostics: Serological screening of infectious diseases, quantification of hormones and tumor markers, and autoimmune antibody detection in hospitals and clinical laboratories operating under ISO 15189 quality systems.
  • Pharmaceutical and biopharmaceutical development: Pharmacokinetic studies, immunogenicity and anti-drug antibody testing, potency assessment of biologics, and lot release testing under GMP-aligned quality management systems.
  • Academic and life science research: Quantification of cytokines, signaling proteins, and biomarkers in cell and animal studies to support mechanistic and translational research.
  • Food safety and agriculture: Detection of allergens, mycotoxins, veterinary drug residues, and adulterants in food matrices as a rapid screening tool prior to confirmatory chromatographic or mass spectrometric analysis.
  • Environmental and veterinary monitoring: Detection of contaminants, pathogens, and hormones in water, soil extracts, and animal specimens.
  • Contract testing: Accredited third-party laboratories apply validated ELISA methods to provide objective, repeatable test reports for manufacturers, importers, and regulatory submission support.

FAQ

What is the detection limit of a typical ELISA kit?

Detection limits vary by analyte and kit design, but most sandwich ELISA kits achieve sensitivity in the pg/mL to low ng/mL range. The exact sensitivity is stated in each kit's certificate of analysis or instructions for use and should be verified during in-house method validation.

Why is my standard curve flat or the signal weak?

Common causes include expired or degraded reagents, incorrect reagent reconstitution, insufficient incubation time, incomplete washing, inadequate substrate development, or a malfunctioning microplate reader. Checking reagent lot validity, repeating the run with fresh standards, and verifying reader wavelength settings usually resolve the issue.

Can I test sample matrices not listed in the kit insert?

Unvalidated matrices may introduce matrix effects that bias results. Before reporting data, perform a spike-recovery and dilution linearity study in the new matrix. If recovery falls outside the 80–120% acceptance range, apply matrix-matched calibration or sample cleanup.

How should samples with concentrations above the standard range be handled?

Dilute the samples with the kit's sample diluent so that the interpolated concentration falls within the linear portion of the standard curve, then multiply the result by the dilution factor. Never extrapolate beyond the highest standard.

What causes high background across all wells?

High background often results from insufficient washing, over-development of the substrate, contaminated wash buffer, or excessive incubation time. Standardizing washing steps, using fresh buffers, and strictly controlling substrate incubation typically reduce background to acceptable levels.

Is a 4PL or linear fit better for ELISA data analysis?

The four-parameter logistic model is preferred for most ELISA standard curves because it fits the sigmoidal response across the full calibration range. Linear regression may only be used for a narrow working range where the response is demonstrably linear, and the chosen model should be justified in the method documentation.

How often should ELISA results be verified by an independent laboratory?

For regulated applications or high-stakes decisions, periodic verification of in-house results by accredited third-party laboratories using orthogonal or confirmatory methods is a recommended practice to demonstrate method robustness and result reliability.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing